BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss ...

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost intracameral implant (Durysta; AbbVie) and the travoprost intracameral implant (iDose ...

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

Franciscan Physicians Hospital is the first hospital in Indiana to purchase Trabectome minimally invasive glaucoma treatment, according to NeoMedix, Inc. Trabectome, developed by NeoMedix, Inc., ...

Glaucoma is one of the most common causes of irreversible vision loss, especially in older adults. It slowly damages the optic nerve and often shows no early signs. Many people do not realize they ...

Context: Glaucoma is a chronic ophthalmic condition affecting approximately 15 million people. Several therapies are currently available (eg, beta-blockers, sympathomimetics, carbonic anhydrase ...

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation is proud to announce it received a transformative $5 million gift from the John and Daria Barry Foundation, the largest ...

Glaucoma is an ophthalmic condition characterized by a multifactorial optic neuropathy in which there is a characteristic acquired loss of optic nerve fibers. [2] In large part, these ill effects have ...